CD58/CD2 is the primary costimulatory pathway in human CD282CD8+ T cells

Journal of Immunology

Volumn 195, Issue 2, 2015, Pages 477-487

  Leitner, Judith ^a   Herndler Brandstetter, Dietmar ^b   Zlabinger, Gerhard J ^a   Grubeck Loebenstein, Beatrix ^b   Steinberger, Peter ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CD2 ANTIGEN; CD28 ANTIGEN; CD8 ANTIGEN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; T LYMPHOCYTE RECEPTOR; PEPTIDE; VIRUS ANTIGEN;

ANTIGEN PRESENTING CELL; ARTICLE; CELL EXPANSION; CELL MEDIATED CYTOTOXICITY; CYTOKINE PRODUCTION; DENDRITIC CELL; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; AGED; AMINO ACID SEQUENCE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHEMISTRY; CYTOLOGY; DEFICIENCY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; IMMUNOPHENOTYPING; LYMPHOCYTE ACTIVATION; MOLECULAR GENETICS; ORTHOMYXOVIRIDAE; PRIMARY CELL CULTURE; T LYMPHOCYTE SUBPOPULATION;

AGED; AMINO ACID SEQUENCE; ANTIGENS, CD2; ANTIGENS, CD28; ANTIGENS, CD58; ANTIGENS, CD8; ANTIGENS, VIRAL; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; GENE EXPRESSION REGULATION; HUMANS; IMMUNOPHENOTYPING; LYMPHOCYTE ACTIVATION; MOLECULAR SEQUENCE DATA; ORTHOMYXOVIRIDAE; PEPTIDES; PRIMARY CELL CULTURE; SIGNAL TRANSDUCTION; T-LYMPHOCYTE SUBSETS;

EID: 84936773099     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1401917     Document Type: Article

References (57)

1. Hayflick, L., and P. S. Moorhead. 1961. The serial cultivation of human diploid cell strains. Exp. Cell Res. 25: 585-621.
2. Effros, R. B., and G. Pawelec. 1997. Replicative senescence of T cells: does the Hayflick Limit lead to immune exhaustion? Immunol. Today 18: 450-454.
3. Campisi, J. 2013. Aging, cellular senescence, and cancer. Annu. Rev. Physiol. 75: 685-705.
4. Goronzy, J. J., and C. M. Weyand. 2005. T cell development and receptor diversity during aging. Curr. Opin. Immunol. 17: 468-475.
5. Effros, R. B. 1997. Loss of CD28 expression on T lymphocytes: A marker of replicative senescence. Dev. Comp. Immunol. 21: 471-478.
6. Vallejo, A. N., J. C. Brandes, C. M. Weyand, and J. J. Goronzy. 1999. Modulation of CD28 expression: distinct regulatory pathways during activation and replicative senescence. J. Immunol. 162: 6572-6579.
7. Vallejo, A. N., C. M. Weyand, and J. J. Goronzy. 2001. Functional disruption of the CD28 gene transcriptional initiator in senescent T cells. J. Biol. Chem. 276: 2565-2570.
8. Boucher, N., T. Dufeu-Duchesne, E. Vicaut, D. Farge, R. B. Effros, and F. Schächter. 1998. CD28 expression in T cell aging and human longevity. Exp. Gerontol. 33: 267-282.
9. Azuma, M., J. H. Phillips, and L. L. Lanier. 1993. CD28-T lymphocytes. An-tigenic and functional properties. J. Immunol. 150: 1147-1159.
10. Fagnoni, F. F., R. Vescovini, M. Mazzola, G. Bologna, E. Nigro, G. Lavagetto, C. Franceschi, M. Passeri, and P. Sansoni. 1996. Expansion of cytotoxic CD8+ CD28-T cells in healthy ageing people, including centenarians. Immunology 88: 501-507.
11. Goronzy, J. J., J. W. Fulbright, C. S. Crowson, G. A. Poland, W. M. O'Fallon, and C. M. Weyand. 2001. Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals. J. Virol. 75: 12182-12187.
12. Almanzar, G., S. Schwaiger, B. Jenewein, M. Keller, D. Herndler-Brandstetter, R. Würzner, D. Schönitzer, and B. Grubeck-Loebenstein. 2005. Long-term cy-tomegalovirus infection leads to significant changes in the composition of the CD8+ T-cell repertoire, which may be the basis for an imbalance in the cytokine production profile in elderly persons. J. Virol. 79: 3675-3683.
13. Pawelec, G., and E. Derhovanessian. 2011. Role of CMV in immune senescence. Virus Res. 157: 175-179.
14. Effros, R. B., R. Allsopp, C. P. Chiu, M. A. Hausner, K. Hirji, L. Wang, C. B. Harley, B. Villeponteau, M. D. West, and J. V. Giorgi. 1996. Shortened telomeres in the expanded CD28-CD8+ cell subset in HIV disease implicate replicative senescence in HIV pathogenesis. AIDS 10: F17-F22.
15. Appay, V., P. R. Dunbar, M. Callan, P. Klenerman, G. M. Gillespie, L. Papagno, G. S. Ogg, A. King, F. Lechner, C. A. Spina, et al. 2002. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat. Med. 8: 379-385.
16. Spaulding, C., W. Guo, and R. B. Effros. 1999. Resistance to apoptosis in human CD8+ T cells that reach replicative senescence after multiple rounds of antigen-specific proliferation. Exp. Gerontol. 34: 633-644.
17. Vallejo, A. N. 2005. CD28 extinction in human T cells: altered functions and the program of T-cell senescence. Immunol. Rev. 205: 158-169.
18. Effros, R. B., M. Dagarag, C. Spaulding, and J. Man. 2005. The role of CD8+ T-cell replicative senescence in human aging. Immunol. Rev. 205: 147-157.
19. Voehringer, D., M. Koschella, and H. Pircher. 2002. Lack of proliferative capacity of human effector and memory T cells expressing killer cell lectinlike receptor G1 (KLRG1). Blood 100: 3698-3702.
20. Sharpe, A. H., and G. J. Freeman. 2002. The B7-CD28 superfamily. Nat. Rev. Immunol. 2: 116-126.
21. Nurieva, R. I., X. Liu, and C. Dong. 2009. Yin-Yang of costimulation: crucial controls of immune tolerance and function. Immunol. Rev. 229: 88-100.
22. Greenwald, R. J., G. J. Freeman, and A. H. Sharpe. 2005. The B7 family revisited. Annu. Rev. Immunol. 23: 515-548.
23. Watts, T. H. 2005. TNF/TNFR family members in costimulation of T cell responses. Annu. Rev. Immunol. 23: 23-68.
24. Leitner, J., K. Grabmeier-Pfistershammer, and P. Steinberger. 2010. Receptors and ligands implicated in human T cell costimulatory processes. Immunol. Lett. 128: 89-97.
25. Bauer, S., V. Groh, J. Wu, A. Steinle, J. H. Phillips, L. L. Lanier, and T. Spies. 1999. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285: 727-729.
26. Damle, N. K., K. Klussman, P. S. Linsley, and A. Aruffo. 1992. Differential costimulatory effects of adhesion molecules B7, ICAM-1, LFA-3, and VCAM-1 on resting and antigen-primed CD4+ T lymphocytes. J. Immunol. 148: 1985-1992.
27. Meuer, S. C., R. E. Hussey, M. Fabbi, D. Fox, O. Acuto, K. A. Fitzgerald, J. C. Hodgdon, J. P. Protentis, S. F. Schlossman, and E. L. Reinherz. 1984. An alternative pathway of T-cell activation: A functional role for the 50 kd T11 sheep erythrocyte receptor protein. Cell 36: 897-906.
28. Hassan, N. J., A. N. Barclay, and M. H. Brown. 2004. Frontline: Optimal T cell activation requires the engagement of CD6 and CD166. Eur. J. Immunol. 34: 930-940.
29. Bukczynski, J., T. Wen, and T. H. Watts. 2003. Costimulation of human CD28-T cells by 4-1BB ligand. Eur. J. Immunol. 33: 446-454.
30. Plunkett, F. J., O. Franzese, H. M. Finney, J. M. Fletcher, L. L. Belaramani, M. Salmon, I. Dokal, D. Webster, A. D. Lawson, and A. N. Akbar. 2007. The loss of telomerase activity in highly differentiated CD8+CD28-CD27-T cells is associated with decreased Akt (Ser473) phosphorylation. J. Immunol. 178: 7710-7719.
31. Waller, E. C., N. McKinney, R. Hicks, A. J. Carmichael, J. G. Sissons, and M. R. Wills. 2007. Differential costimulation through CD137 (4-1BB) restores proliferation of human virus-specific "effector memory" (CD28(-) CD45RA (HI)) CD8(+) T cells. Blood 110: 4360-4366.
32. Brunner, S., D. Herndler-Brandstetter, C. R. Arnold, G. J. Wiegers, A. Villunger, M. Hackl, J. Grillari, M. Moreno-Villanueva, A. Bürkle, and B. Grubeck-Loe-benstein. 2012. Upregulation of miR-24 is associated with a decreased DNA damage response upon etoposide treatment in highly differentiated CD8(+) T cells sensitizing them to apoptotic cell death. Aging Cell 11: 579-587.
33. Leitner, J., W. Kuschei, K. Grabmeier-Pfistershammer, R. Woitek, E. Kriehuber, O. Majdic, G. Zlabinger, W. F. Pickl, and P. Steinberger. 2010. T cell stimulator cells, an efficient and versatile cellular system to assess the role of costimulatory ligands in the activation of human T cells. J. Immunol. Methods 362: 131-141.
34. Leitner, J., C. Klauser, W. F. Pickl, J. Stöckl, O. Majdic, A. F. Bardet, D. P. Kreil, C. Dong, T. Yamazaki, G. Zlabinger, et al. 2009. B7-H3 is a potent inhibitor of human T-cell activation: no evidence for B7-H3 and TREML2 interaction. Eur. J. Immunol. 39: 1754-1764.
35. Leitner, J., A. Rieger, W. F. Pickl, G. Zlabinger, K. Grabmeier-Pfistershammer, and P. Steinberger. 2013. TIM-3 does not act as a receptor for galectin-9. PLoS Pathog. 9: e1003253.
36. Steinberger, P., O. Majdic, S. V. Derdak, K. Pfistershammer, S. Kirchberger, C. Klauser, G. Zlabinger, W. F. Pickl, J. Stöckl, and W. Knapp. 2004. Molecular characterization of human 4Ig-B7-H3, a member of the B7 family with four Ig-like domains. J. Immunol. 172: 2352-2359.
37. Kober, J., J. Leitner, C. Klauser, R. Woitek, O. Majdic, J. Stöckl, D. Herndler-Brandstetter, B. Grubeck-Loebenstein, B. M. Reipert, W. F. Pickl, et al. 2008. The capacity of the TNF family members 4-1BBL, OX40L, CD70, GITRL, CD30L and LIGHT to costimulate human T cells. Eur. J. Immunol. 38: 2678-2688.
38. Brenchley, J. M., N. J. Karandikar, M. R. Betts, D. R. Ambrozak, B. J. Hill, L. E. Crotty, J. P. Casazza, J. Kuruppu, S. A. Migueles, M. Connors, et al. 2003. Expression of CD57 defines replicative senescence and antigen-induced apo-ptotic death of CD8+ T cells. Blood 101: 2711-2720.
39. Strioga, M., V. Pasukoniene, and D. Characiejus. 2011. CD8+ CD28-and CD8+ CD57+ T cells and their role in health and disease. Immunology 134: 17-32.
40. Skånland, S. S., K. Moltu, T. Berge, E. M. Aandahl, and K. Taskén. 2014. T-cell co-stimulation through the CD2 and CD28 co-receptors induces distinct signalling responses. Biochem. J. 460: 399-410.
41. Kalland, M. E., N. G. Oberprieler, T. Vang, K. Taskén, and K. M. Torgersen. 2011. T cell-signaling network analysis reveals distinct differences between CD28 and CD2 costimulation responses in various subsets and in the MAPK pathway between resting and activated regulatory T cells. J. Immunol. 187: 5233-5245.
42. Siliciano, R. F., J. C. Pratt, R. E. Schmidt, J. Ritz, and E. L. Reinherz. 1985. Activation of cytolytic T lymphocyte and natural killer cell function through the T11 sheep erythrocyte binding protein. Nature 317: 428-430.
43. Kanner, S. B., N. K. Damle, J. Blake, A. Aruffo, and J. A. Ledbetter. 1992. CD2/LFA-3 ligation induces phospholipase-C gamma 1 tyrosine phosphorylation and regulates CD3 signaling. J. Immunol. 148: 2023-2029.
44. Hendriks, J., Y. Xiao, J. W. Rossen, K. F. van der Sluijs, K. Sugamura, N. Ishii, and J. Borst. 2005. During viral infection of the respiratory tract, CD27, 4-1BB, and OX40 collectively determine formation of CD8+ memory T cells and their capacity for secondary expansion. J. Immunol. 175: 1665-1676.
45. Weng, N. P., A. N. Akbar, and J. Goronzy. 2009. CD28(-) T cells: their role in the age-associated decline of immune function. Trends Immunol. 30: 306-312.
46. Onyema, O. O., R. Njemini, I. Bautmans, W. Renmans, M. De Waele, and T. Mets. 2012. Cellular aging and senescence characteristics of human T-lym-phocytes. Biogerontology 13: 169-181.
47. Herndler-Brandstetter, D., K. Landgraf, A. Tzankov, B. Jenewein, R. Brunauer, G. T. Laschober, W. Parson, F. Kloss, R. Gassner, G. Lepperdinger, and B. Grubeck-Loebenstein. 2012. The impact of aging on memory T cell pheno-type and function in the human bone marrow. J. Leukoc. Biol. 91: 197-205.
48. Henson, S. M., O. Franzese, R. Macaulay, V. Libri, R. I. Azevedo, S. Kiani-Alikhan, F. J. Plunkett, J. E. Masters, S. Jackson, S. J. Griffiths, et al. 2009. KLRG1 signaling induces defective Akt (ser473) phosphorylation and prolifer-ative dysfunction of highly differentiated CD8+ T cells. Blood 113: 6619-6628.
49. Henson, S. M., R. Macaulay, O. Franzese, and A. N. Akbar. 2012. Reversal of functional defects in highly differentiated young and old CD8 T cells by PDL blockade. Immunology 135: 355-363.
50. Chen, L., and D. B. Flies. 2013. Molecular mechanisms of T cell co-stimulation and co-inhibition. Nat. Rev. Immunol. 13: 227-242.
51. Maue, A. C., E. J. Yager, S. L. Swain, D. L. Woodland, M. A. Blackman, and L. Haynes. 2009. T-cell immunosenescence: lessons learned from mouse models of aging. Trends Immunol. 30: 301-305.
52. High, K. P., A. N. Akbar, and J. Nikolich-Zugich. 2012. Translational research in immune senescence: assessing the relevance of current models. Semin. Immunol. 24: 373-382.
53. Akbar, A. N., M. V. Soares, F. J. Plunkett, and M. Salmon. 2000. Differential regulation of CD8+ T cell senescence in mice and men. Mech. Ageing Dev. 121: 69-76.
54. Engwerda, C. R., B. S. Handwerger, and B. S. Fox. 1994. Aged T cells are hyporesponsive to costimulation mediated by CD28. J. Immunol. 152: 3740-3747.
55. Hamann, D., P. A. Baars, M. H. Rep, B. Hooibrink, S. R. Kerkhof-Garde, M. R. Klein, and R. A. van Lier. 1997. Phenotypic and functional separation of memory and effector human CD8+ T cells. J. Exp. Med. 186: 1407-1418.
56. Borthwick, N. J., M. Lowdell, M. Salmon, and A. N. Akbar. 2000. Loss of CD28 expression on CD8(+) T cells is induced by IL-2 receptor gamma chain signalling cytokines and type I IFN, and increases susceptibility to activation-induced apoptosis. Int. Immunol. 12: 1005-1013.
57. Ortiz-Suárez, A., and R. A. Miller. 2002. A subset of CD8 memory T cells from old mice have high levels of CD28 and produce IFN-gamma. Clin. Immunol. 104: 282-292.